HomeCAI • NASDAQ
Caris Life Sciences Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 181.40M | 81.31% |
Operating expense | 131.67M | 25.93% |
Net income | -71.79M | -8.47% |
Net profit margin | -39.58 | 40.17% |
Earnings per share | -1.11 | — |
EBITDA | -11.58M | 79.10% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 721.18M | — |
Total assets | 955.06M | — |
Total liabilities | 502.15M | — |
Total equity | 452.90M | — |
Shares outstanding | 281.22M | — |
Price to book | 23.75 | — |
Return on assets | -7.21% | — |
Return on capital | -9.59% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -71.79M | -8.47% |
Cash from operations | 7.29M | 111.58% |
Cash from investing | -1.39M | 46.45% |
Cash from financing | 681.40M | 528,318.60% |
Net change in cash | 687.40M | 1,147.37% |
Free cash flow | 29.85M | — |
Previous close
$38.23
Day range
$37.59 - $39.18
Year range
$25.40 - $42.50
Market cap
10.70B USD
Avg Volume
658.23K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2008
Headquarters
Website
Employees
1,769